NCT02955706View on ClinicalTrials.gov

Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

265

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

September 29, 2018

Study Completion Date

January 25, 2019

Conditions
Alzheimer Disease
Interventions
DRUG

Acetyl-L-Carnitine

TID

DRUG

Placebo of Acetyl-L-Carnitine

TID

Trial Locations (1)

KS013

Konkuk university medical center, Seoul

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT02955706 - Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease | Biotech Hunter | Biotech Hunter